News - Cancer Therapeutics
2011-12-03 11:08:04
MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla.
2011-11-16 09:55:02
A potential breakthrough in treating late-stage ovarian cancer has come from University of Guelph researchers who have discovered a peptide that shrinks advanced tumors and improves survival rates for this deadly but often undetected disease.